These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 2571226)
1. Disposition and pharmacokinetics of the new neuroleptic drug VUFB 15496 (cloflumide) in rats. Lapka R; Smolík S; Franc Z Act Nerv Super (Praha); 1989 Apr; 31(1):44-5. PubMed ID: 2571226 [No Abstract] [Full Text] [Related]
2. Disposition of [3H]cloflumide, a new neuroleptic drug, in rats. Lapka R; Franc Z; Smolík S Eur J Drug Metab Pharmacokinet; 1987; 12(2):103-8. PubMed ID: 2891530 [TBL] [Abstract][Full Text] [Related]
3. [Biochemistry of drugs. 31. Pharmacokinetics of the labeled neuroleptic 3-fluoro-10-[4-(2-hydroxyethyl)piperazino]8-isopropyl- 10,11-dihydrodibenzo[b,f]thiepine--[10-14C]-isofloxythe pine after a single oral dose and intravenous administration in rats]. Franc Z; Smolík S; Francová V; Frühaufová-Ausková M; Selecká A; Janda J; Schlehrová M Cesk Farm; 1983 Dec; 32(9-10):326-31. PubMed ID: 6141852 [No Abstract] [Full Text] [Related]
4. The difference in oxyprothepine and dokloxythepine biotransformation in rat liver microsomes. Helia O; Paulikovà I Pharmazie; 1991 Oct; 46(10):750. PubMed ID: 1687081 [No Abstract] [Full Text] [Related]
5. Pharmacokinetic evaluation of LASSBio-579: an N-phenylpiperazine antipsychotic prototype. Conrado DJ; Verli H; Neves G; Fraga CA; Barreiro EJ; Rates SM; Dalla Costa T J Pharm Pharmacol; 2008 Jun; 60(6):699-707. PubMed ID: 18498705 [TBL] [Abstract][Full Text] [Related]
6. [Experimental pharmacokinetics of the new neurotensine-derived antipsychotic drug dilept]. Zherdev VP; Boĭko SS; Mesonzhnik NV; Appolonova SA; Rodchenkov GN; Ostrovskaia RU; Gudasheva TA; Seredenin SB Eksp Klin Farmakol; 2009; 72(3):16-21. PubMed ID: 19642587 [TBL] [Abstract][Full Text] [Related]
7. Single oral dose kinetics of zotepine and its relationship to prolactin response and side effects. Tanaka O; Kondo T; Otani K; Yasui N; Tokinaga N; Kaneko S Ther Drug Monit; 1998 Feb; 20(1):117-9. PubMed ID: 9485566 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and presystemic hepatic first-pass elimination of a novel sigma receptor antagonist, DuP 734, in the rat. Kapil RP; Lam GN Drug Metab Dispos; 1995 May; 23(5):603-6. PubMed ID: 7587939 [No Abstract] [Full Text] [Related]
9. Pharmacokinetics of 3H-pipethiaden after single oral and intravenous administration in rats. Lapka R; Franc Z; Smolik S Arzneimittelforschung; 1985; 35(2):486-8. PubMed ID: 4039570 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tissue distribution of a new heterocyclic N-phenylpiperazine derivative (LASSBio-581) in rats. Tasso L; Neves G; Menegatti R; Fraga CA; Barreiro E; Eifler-Lima V; Rates SM; Costa TD Eur J Pharm Sci; 2005 Oct; 26(2):194-202. PubMed ID: 16076552 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. Manjunath K; Venkateswarlu V J Control Release; 2005 Oct; 107(2):215-28. PubMed ID: 16014318 [TBL] [Abstract][Full Text] [Related]
12. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration. Plänitz V; Jähnchen E Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of 3-[bis(2-hydroxyethyl)amino]acetophenone [4,5-diphenyloxazolyl-(2)]hydrazone (ZIMET 98/69) in rats. Amlacher R; Horn U; Kramarczyk K; Ulbricht H; Hoffmann H Pharmazie; 1982 Jan; 37(1):33-5. PubMed ID: 6122223 [TBL] [Abstract][Full Text] [Related]
14. Disposition of [14C]avitriptan in rats and humans. Marathe PH; Greene DS; Barbhaiya RH Drug Metab Dispos; 1997 Jul; 25(7):881-8. PubMed ID: 9224783 [TBL] [Abstract][Full Text] [Related]
15. [Biochemistry of drugs. XXVI. Pharmacokinetics and metabolism of the neuroleptic drug 2-chloro-10-/4-(2-hydroxyethyl)piperazino/10,11-dihydrodibenzo(b,f)thiepine (docloxythepin)]. Franc Z; Queisnerová M; Roubal Z; Smolík S; Svátek E; Janda J; Selecká A; Karousová J Cesk Farm; 1980 Sep; 29(7):244-9. PubMed ID: 6110485 [No Abstract] [Full Text] [Related]
16. Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs. Kawai K; Kawasaki-Tokui Y; Odaka T; Tsuruta F; Kazui M; Iwabuchi H; Nakamura T; Kinoshita T; Ikeda T; Yoshioka T; Komai T; Nakamura K Arzneimittelforschung; 1997 Apr; 47(4):356-68. PubMed ID: 9150855 [TBL] [Abstract][Full Text] [Related]
17. Distribution and metabolism of the antipsychotic agent mazapertine succinate in rats. Caldwell GW; Wu WN; McKown LA; Diane Gauthier A; Masucci JA; Jones WJ; Leo GC; Reitz AB J Pharm Biomed Anal; 2006 May; 41(2):500-9. PubMed ID: 16386397 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of 14C-ambazone in rats. Kühnel HJ; Amlacher R; Kramarczyk K; Schulze W Pharmazie; 1988 Mar; 43(3):197-9. PubMed ID: 3380864 [TBL] [Abstract][Full Text] [Related]
19. Disposition of salmeterol xinafoate in laboratory animals and humans. Manchee GR; Barrow A; Kulkarni S; Palmer E; Oxford J; Colthup PV; Maconochie JG; Tarbit MH Drug Metab Dispos; 1993; 21(6):1022-8. PubMed ID: 7905380 [TBL] [Abstract][Full Text] [Related]
20. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats. Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]